<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=16228"><dc:title>Učinkovitost in varnost alpeliziba pri zdravljenju HR+, HER2-, PIK3CA-mutiranega razsejanega raka dojk</dc:title><dc:creator>Godina,	Eva	(Avtor)
	</dc:creator><dc:creator>Ribnikar,	Domen	(Avtor)
	</dc:creator><dc:creator>Borštnar,	Simona	(Avtor)
	</dc:creator><dc:subject>onkologija</dc:subject><dc:subject>rak dojke</dc:subject><dc:subject>kemoterapija</dc:subject><dc:date>2022</dc:date><dc:date>2023-02-09 13:44:34</dc:date><dc:type>Neznano</dc:type><dc:identifier>16228</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>